Literature DB >> 6815070

The inhibition by lysine of the activation of the first component of complement, C1.

A Takada, Y Takada.   

Abstract

Lysine prevented the activation of Cl at low ionic strength or by heat aggregated IgG (aggIgG) measured by the hydrolysis of acetyl tyrosine ethyl ester (ATEe) by Cls. When serum was mixed with aggIgG, complement was activated and consumed. If lysine was present in the serum containing aggIgG, the activation of complement, thus its consumption, was inhibited in a dose-response manner. Cl haemolysis assay which measures the Cl activity to interact with EA (erythrocytes bound with antibody) was used to study the effects of lysine. The results indicate that 50% of Cl haemolysis was inhibited at 3 mM of lysine. Crossed immunoelectrophoresis indicates that Cl in the serum was activated by aggIgG, but Cls thus formed seemed to be soon complexed with Cl inactivator. The presence of lysine prevented the conversion of Cls to Cls completely. It might be possible that lysine binds with the binding sites on Clq, thus preventing the interaction of Clq and C gamma 2.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815070      PMCID: PMC1555565     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.

Authors:  A L HAINES; I H LEPOW
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  Measurement of the rate of plasmin action on synthetic substrates.

Authors:  P S ROBERTS
Journal:  J Biol Chem       Date:  1958-05       Impact factor: 5.157

3.  C1 subcomponent conplexes in normal and pathological sera studied by crossed immunoelectrophoresis.

Authors:  A B Laurell; U Mårtensson; A G Sjöholm
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-12

4.  Inhibition of the classical and alternative pathways by amino acids and their derivatives.

Authors:  Y Takada; Y Arimoto; H Mineda; A Takada
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

5.  A gross structure of an activated form of a subunit of the first component of human complement. Clr.

Authors:  K Takahashi; S Nagasawa; J Koyama
Journal:  FEBS Lett       Date:  1975-07-15       Impact factor: 4.124

6.  Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement.

Authors:  R C Siegel; V N Schumaker; P H Poon
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

7.  The Clq receptor site on immunoglobulin G.

Authors:  D R Burton; J Boyd; A D Brampton; S B Easterbrook-Smith; E J Emanuel; J Novotny; T W Rademacher; M R van Schravendijk; M J Sternberg; R A Dwek
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

8.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

9.  The first component of complement. I. Purification and properties of native C1.

Authors:  R G Medicus; R M Chapuis
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

10.  Influence of omega-aminoacids on the activation of the first component of complement at low ionic strength.

Authors:  Y Takada; A Takada
Journal:  Thromb Haemost       Date:  1981-02-23       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.